U.S.–Venezuela Relations Show Signs of Thaw as Top Envoy Visits Caracas 
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
China Factory Activity Slips in January as Weak Demand Weighs on Growth Outlook 
Russia Stocks End Flat as MOEX Closes Unchanged Amid Mixed Global Signals 
NASA and SpaceX Target Crew-11 Undocking From ISS Amid Medical Concern 
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 
Indonesia Stocks Face Fragile Sentiment After MSCI Warning and Market Rout 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug 
A new diagnostic method that ascertains if a person is suffering from Parkinson’s disease or dementia by looking at the manner of walking has been patented.
A new diagnostic technique developed by a St. Mary's Hospital research team in Uijeongbu has been patented and put up for patent registration, which analyses data from an individual's shoes to detect neurological disorders.
Most degenerative brain disorders, such as Parkinson's disease, dementia, and Lou Gehrig's disease, occur at an older age.
Currently, a costly MRI or a PET scan is required for such diagnosis, as well as frequent visits to the hospital.
The new approach, on the other hand, employs a "smart insole" that is placed inside a shoe and collects data from its sensors, which is then analyzed to assess the brain health of the wearer.
The new technique achieved an accuracy of 98.1 percent for the diagnosis of Parkinson's disease, as well as 83.2 percent for differentiating whether an illness is vascular or degenerative.
